These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24388825)

  • 1. (18)F-FDG PET/MR in herpes simplex virus encephalitis: A case study.
    Schillaci O; Chiaravalloti A; Chiaravalloti A; Travascio L; Floris R; Simonetti G
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):249-50. PubMed ID: 24388825
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT.
    Wong KK; Tolia B; Bohnen N
    Clin Nucl Med; 2008 Jun; 33(6):443-4. PubMed ID: 18496462
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventral striatal and septal area hypermetabolism on FDG-PET in herpes simplex viral encephalitis.
    Singhal T; Solomon I; Akbik F; Smirnakis S; Vaitkevicius H
    J Neurovirol; 2020 Feb; 26(1):118-120. PubMed ID: 31286440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
    Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Seki S; Yui M; Yamagata H; Aoyagi K; Matsumoto S; Sugimura K
    Radiology; 2015 Jun; 275(3):849-61. PubMed ID: 25584709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
    Beheshti M; Kim CK
    PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
    Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
    Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.
    Nakahara M; Ito M; Hattori N; Magota K; Takahata M; Nagahama K; Sudo H; Kamishima T; Tamaki N; Iwasaki N
    Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
    Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
    Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study.
    Bolcaen J; Acou M; Mertens K; Hallaert G; Van den Broecke C; Achten E; Goethals I
    J Neuroimaging; 2013 Jul; 23(3):431-6. PubMed ID: 23279326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR.
    Platzek I; Beuthien-Baumann B; Ordemann R; Maus J; Schramm G; Kitzler HH; Laniado M; Kotzerke J; van den Hoff J
    Acad Radiol; 2014 Oct; 21(10):1314-9. PubMed ID: 25086953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
    Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Basic Principles of FDG-PET/CT Imaging.
    Basu S; Hess S; Nielsen Braad PE; Olsen BB; Inglev S; Høilund-Carlsen PF
    PET Clin; 2014 Oct; 9(4):355-70, v. PubMed ID: 26050942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulnerable plaque on the common iliac artery detected by (18)F-FDG PET/MRI.
    Masuda A; Yamaki T; Sakamoto N; Kunii H; Ito H; Nanbu T; Kubo H; Hara T; Takenoshita S; Takeishi Y
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):793-4. PubMed ID: 26753601
    [No Abstract]   [Full Text] [Related]  

  • 18. ¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
    Segtnan EA; Hess S; Grupe P; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):59-73. PubMed ID: 25455880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MR imaging: current and future applications for cardiovascular disease.
    Naeger DM; Behr SC
    Magn Reson Imaging Clin N Am; 2015 Feb; 23(1):95-103. PubMed ID: 25476678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.